Empagliflozin and Metformin Hydrochloride Tablets 12.5/1000 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
MFDS item code 202302639 · Approved 2023.09.05
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood glucose control in adult patients with type 2 diabetes by combining empagliflozin and metformin. It can be administered as an adjunct to dietary and exercise therapy to effectively manage blood glucose levels. Caution is especially necessary when used in adult patients with type 2 diabetes who have cardiovascular disease and whose blood glucose is insufficiently controlled; clinical trial information should be consulted. Overall, this medication helps in blood glucose control and contributes to diabetes management.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication can cause a rare side effect known as severe lactic acidosis, so caution is required, particularly in patients with impaired kidney function, severe infections, dehydration, or heart disease. There is an increased risk of hypoglycemia when taken with insulin or sulfonylureas, so blood glucose levels should be closely monitored. Patients with moderate to severe renal impairment or in situations where acute kidney injury is a concern should not take this medication. When undergoing tests that use contrast agents, this medication should be temporarily discontinued, and resumed only after normal kidney function is confirmed post-test. In cases of scheduled surgery, this medication should be discontinued 48 hours prior to the procedure and restarted only after kidney function has normalized post-surgery. It is safest for pregnant or breastfeeding women to avoid this medication. This medication may increase the risk of urinary infections and genital infections; consult a healthcare provider immediately if symptoms of infection appear. Dehydration or hypotension may occur due to fluid volume loss during treatment, so special caution is required for the elderly or patients with cardiovascular disease. This medication may decrease vitamin B12 levels, so regular blood tests should be conducted during long-term use. Excessive alcohol consumption can increase the risk of side effects from this medication, so it is advisable to avoid it. Hypoglycemic symptoms may occur, so caution is necessary if meals are skipped or irregular. Regular monitoring of blood glucose levels is recommended while taking this medication, and any unusual symptoms should be discussed with a doctor immediately. Given the potential for drug interactions, inform your healthcare provider about any other medications being taken, especially those that may affect kidney function. This medication is not recommended for children under 18, and the elderly should take it with regular checks of kidney function. In cases of overdose, seek immediate medical attention, as the components of this medication can be removed through hemodialysis. Store this medication out of the reach of children, and keep it in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is recommended to keep the medication at room temperature between 1 degree Celsius and 30 degrees Celsius, away from extreme heat or cold.
Biconvex oval film-coated tablets with a dark brownish purple color
60 tablets/bottle, 10 tablets/box [10 tablets/PTP X 1], 60 tablets/box [60 tablets/PTP X 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.